Achim Rody

Summary

Affiliation: Frankfurt am Main
Country: Germany

Publications

  1. ncbi Androgen receptor expression in ductal carcinoma in situ of the breast: not a helpful marker for classification such as estrogen receptor alpha and progesterone receptor
    Achim Rody
    Department of Obstetrics and Gynecology, University Hospital of Frankfurt, Frankfurt, Germany
    Appl Immunohistochem Mol Morphol 13:25-9. 2005
  2. pmc T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers
    Achim Rody
    Department of Obstetrics and Gynecology, JW Goethe University, Theodor Stern Kai 7, Frankfurt, Germany
    Breast Cancer Res 11:R15. 2009
  3. ncbi The erbB2+ cluster of the intrinsic gene set predicts tumor response of breast cancer patients receiving neoadjuvant chemotherapy with docetaxel, doxorubicin and cyclophosphamide within the GEPARTRIO trial
    A Rody
    Department of Obstetrics and Gynecology, J W Goethe University, Frankfurt, Germany
    Breast 16:235-40. 2007
  4. ncbi [Diagnosis and therapy of breast cancer--meeting highlights ASCO 2005]
    A Rody
    Zentrum für Gynäkologie und Geburtshilfe, J W Goethe Universität Frankfurt, Frankfurt Main
    Zentralbl Gynakol 127:389-94. 2005
  5. ncbi Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures
    A Rody
    Department of Obstetrics and Gynecology, J W Goethe University, Frankfurt, Germany
    Zentralbl Gynakol 128:76-81. 2006
  6. ncbi Differentially expressed genes of reprogrammed human pluripotent stem cells in breast cancer
    A Rody
    Department of Obstetrics and Gynecology, J W Goethe University, Theodor Stern Kai 7, D 60590 Frankfurt, Germany
    Eur J Cancer 44:1789-92. 2008
  7. doi Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer
    A Rody
    Department of Obstetrics and Gynecology, JW Goethe University, Frankfurt, Germany
    Breast Cancer Res Treat 113:457-66. 2009
  8. ncbi [Molecular diagnostic and targeted therapy--"Barking dogs are going to bite": presentations from the 42nd Annual Meeting of the American Society of Clinical Oncology, Atlanta 2006]
    A Rody
    Klinik fur Gynakologie und Geburtshilfe, J W Goethe Universitat, Frankfurt am Main
    Zentralbl Gynakol 128:233-41. 2006
  9. ncbi Gene expression profiling of breast cancer patients treated with docetaxel, doxorubicin, and cyclophosphamide within the GEPARTRIO trial: HER-2, but not topoisomerase II alpha and microtubule-associated protein tau, is highly predictive of tumor response
    A Rody
    Department of Obstetrics and Gynecology, J W Goethe University, Theodor Stern Kai 7, 60590 Frankfurt, Germany
    Breast 16:86-93. 2007
  10. doi "Stem cell like" breast cancers-a model for the identification of new prognostic/predictive markers in endocrine responsive breast cancer exemplified by Plexin B1
    A Rody
    Department of Obstetrics and Gynecology, J W Goethe University, Theodor Stern Kai 7, D 60590 Frankfurt, Germany
    Eur J Obstet Gynecol Reprod Biol 139:11-5. 2008

Detail Information

Publications59

  1. ncbi Androgen receptor expression in ductal carcinoma in situ of the breast: not a helpful marker for classification such as estrogen receptor alpha and progesterone receptor
    Achim Rody
    Department of Obstetrics and Gynecology, University Hospital of Frankfurt, Frankfurt, Germany
    Appl Immunohistochem Mol Morphol 13:25-9. 2005
    ..The immunohistochemical assessment of AR status, therefore, may not help in providing a more objective way of classifying DCIS...
  2. pmc T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers
    Achim Rody
    Department of Obstetrics and Gynecology, JW Goethe University, Theodor Stern Kai 7, Frankfurt, Germany
    Breast Cancer Res 11:R15. 2009
    ..However, specific lymphocytes might also promote tumor progression by shifting the cytokine milieu in the tumor...
  3. ncbi The erbB2+ cluster of the intrinsic gene set predicts tumor response of breast cancer patients receiving neoadjuvant chemotherapy with docetaxel, doxorubicin and cyclophosphamide within the GEPARTRIO trial
    A Rody
    Department of Obstetrics and Gynecology, J W Goethe University, Frankfurt, Germany
    Breast 16:235-40. 2007
    ..6%), basal-like (30.0%) and luminal (13.6%) cluster (P=0.215). Our data suggest that the molecular tumor subtypes based on the "intrinsic gene set" can be used to predict tumor response according to NAC...
  4. ncbi [Diagnosis and therapy of breast cancer--meeting highlights ASCO 2005]
    A Rody
    Zentrum für Gynäkologie und Geburtshilfe, J W Goethe Universität Frankfurt, Frankfurt Main
    Zentralbl Gynakol 127:389-94. 2005
  5. ncbi Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures
    A Rody
    Department of Obstetrics and Gynecology, J W Goethe University, Frankfurt, Germany
    Zentralbl Gynakol 128:76-81. 2006
    ..Furthermore we evaluated the predictive significance of prognostic gene signatures as described by Sorlie, van't Veer and Ahr for response to neoadjuvant chemotherapy...
  6. ncbi Differentially expressed genes of reprogrammed human pluripotent stem cells in breast cancer
    A Rody
    Department of Obstetrics and Gynecology, J W Goethe University, Theodor Stern Kai 7, D 60590 Frankfurt, Germany
    Eur J Cancer 44:1789-92. 2008
    ..This analysis reveals two breast cancer subgroups with stem cell-like features, differing in ER-status and proliferation as well as in their clinical course of disease...
  7. doi Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer
    A Rody
    Department of Obstetrics and Gynecology, JW Goethe University, Frankfurt, Germany
    Breast Cancer Res Treat 113:457-66. 2009
    ..There is growing evidence that TOP2A protein expression is a strong prognostic and TOP2A gene amplification might be a predictive marker (particularly for the use of anthracyclines)...
  8. ncbi [Molecular diagnostic and targeted therapy--"Barking dogs are going to bite": presentations from the 42nd Annual Meeting of the American Society of Clinical Oncology, Atlanta 2006]
    A Rody
    Klinik fur Gynakologie und Geburtshilfe, J W Goethe Universitat, Frankfurt am Main
    Zentralbl Gynakol 128:233-41. 2006
    ..In this year again there have been registered an increasing number of interesting contributions from Germany, which also received international attention...
  9. ncbi Gene expression profiling of breast cancer patients treated with docetaxel, doxorubicin, and cyclophosphamide within the GEPARTRIO trial: HER-2, but not topoisomerase II alpha and microtubule-associated protein tau, is highly predictive of tumor response
    A Rody
    Department of Obstetrics and Gynecology, J W Goethe University, Theodor Stern Kai 7, 60590 Frankfurt, Germany
    Breast 16:86-93. 2007
    ..017) as well as overall response (P=0.037) and clinical complete response (cCR, P=0.050). In contrast, for both TOPO IIalpha and MAPT no correlation with pCR was observed in our sample group...
  10. doi "Stem cell like" breast cancers-a model for the identification of new prognostic/predictive markers in endocrine responsive breast cancer exemplified by Plexin B1
    A Rody
    Department of Obstetrics and Gynecology, J W Goethe University, Theodor Stern Kai 7, D 60590 Frankfurt, Germany
    Eur J Obstet Gynecol Reprod Biol 139:11-5. 2008
    ..032; ER positive: p=0.022). In conclusion those strategies of gene expression analysis in a context of biological meaningful classifications could be helpful to reveal new prognostic/predictive markers...
  11. ncbi Use of goserelin in the treatment of breast cancer
    Achim Rody
    Department of Obstetrics and Gynecology, JW Goethe University, Theodor Stern Kai 7, D 60590 Frankfurt, Germany
    Expert Rev Anticancer Ther 5:591-604. 2005
    ..Treatment decisions depend upon adjuvant endocrine pretreatment. Clinical data regarding ovarian protection by synchronous use of gonadotropin-releasing hormone in young breast cancer patients receiving chemotherapy are incoherent...
  12. ncbi Estrogen receptor alpha and beta, progesterone receptor, pS2 and HER-2/neu expression delineate different subgroups in ductal carcinoma in situ of the breast
    Achim Rody
    Department of Obstetrics and Gynecology, University of Hospital of Muenster, Germany
    Oncol Rep 12:695-9. 2004
    ..012). In contrast, 50.0% of her-2/neu negative DCIS expressed ER-beta receptor (p=0.052). We propose that there are subpopulations of DCIS which can be described by distinct endocrine-associated expression patterns...
  13. ncbi [Forensic aspects of female breast reconstructive surgery]
    K Ulsenheimer
    Maximiliansplatz 12, 80333 München
    Zentralbl Gynakol 127:66-70. 2005
  14. ncbi [San Antonio Breast Cancer Symposium -- highlights 2004]
    A Rody
    Klinik fur Gynakologie und Geburtshilfe, J W Goethe Universitat, Frankfurt, Germany
    Zentralbl Gynakol 127:59-65. 2005
    ..The morbidity of this method is low compared with conventional axillary dissection in multicenter studies. Local tumor control is an important parameter which offers a significant survival benefit in all age cohorts...
  15. doi Data-driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancer
    Thomas Karn
    Department of Obstetrics and Gynecology, J W Goethe University, Theodor Stern Kai 7, 60590, Frankfurt, Germany
    Breast Cancer Res Treat 120:567-79. 2010
    ..In contrast, markers displaying a continuous distribution like proliferation markers as Ki67 rather describe the composition of the mixture of cells in the tumor...
  16. doi Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance
    Thomas Karn
    Department of Obstetrics and Gynecology, J W Goethe University, Theodor Stern Kai 7, 60590 Frankfurt, Germany
    Breast Cancer Res Treat 130:409-20. 2011
    ..However, based on previous findings of NHERF1 functioning in PI3K signalling from basic research, these tumors might be appropriate candidates for a targeted therapy of the PI3K/Akt pathway...
  17. ncbi Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer
    Eugen Ruckhäberle
    Department of Gynecology, J W Goethe University, 60590, Frankfurt, Germany
    Breast Cancer Res Treat 112:41-52. 2008
    ..Targeting of the sphingolipid rheostat may thus open new treatment options...
  18. doi Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancer
    Eugen Ruckhäberle
    Department of Gynecology, J W Goethe University, Frankfurt, Germany
    J Cancer Res Clin Oncol 135:81-90. 2009
    ....
  19. doi Loss of Plexin B1 is highly prognostic in low proliferating ER positive breast cancers--results of a large scale microarray analysis
    Achim Rody
    Department of Obstetrics and Gynecology, J W Goethe University, Theodor Stern Kai 7, D 60590 Frankfurt, Germany
    Eur J Cancer 45:405-13. 2009
    ..In conclusion, this study confirms our previous observations suggesting Plexin B1 as a new prognostic marker in ER positive breast cancers...
  20. pmc A clinically relevant gene signature in triple negative and basal-like breast cancer
    Achim Rody
    Department of Obstetrics and Gynecology, J W Goethe University, Theodor Stern Kai 7, Frankfurt, 60590, Germany
    Breast Cancer Res 13:R97. 2011
    ..Triple negative breast cancers (TNBC) are clinically heterogeneous and prognostic markers and biology-based therapies are needed to better treat this disease...
  21. doi Differential expression of claudins in human endometrium and endometriosis
    Regine Gaetje
    Department of Obstetrics and Gynecology, Johann Wolfgang Goethe University, Frankfurt, Germany
    Gynecol Endocrinol 24:442-9. 2008
    ..The downregulation of various members of the claudin family may contribute to endometrial cell detachment and increase the number of cells invading pelvic organs...
  22. pmc Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures
    Thomas Karn
    Department of Obstetrics and Gynecology, J W Goethe University, Frankfurt, Germany
    PLoS ONE 6:e28403. 2011
    ..The identification of prognostic signatures from TNBC cohorts was limited in the past due to small sample sizes...
  23. ncbi Expression of membrane-type 5 matrix metalloproteinase in human endometrium and endometriosis
    Regine Gaetje
    Department of Obstetrics and Gynecology, Johann Wolfgang Goethe University, Frankfurt, Germany
    Gynecol Endocrinol 23:567-73. 2007
    ..Various members of the MMPs also seem to play an important role in the invasion process of endometriosis; however, so far only a limited number of studies have focused on membrane-associated MMPs...
  24. ncbi Expression of endothelin-1, endothelin-A, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up
    Pia Wülfing
    Department of Obstetrics and Gynecology, Gerhard Domagk Institute of Pathology, Westfalische Wilhelms University, 48129 Munster, Germany
    Clin Cancer Res 9:4125-31. 2003
    ..In this study, we evaluated the expression of ET-1 and ET receptors in breast carcinomas and determined its clinical and prognostic significance...
  25. ncbi Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1
    Achim Rody
    Department of Obstetrics and Gynecology, Johann Wolfgang Goethe University, Frankfurt, Germany
    Clin Cancer Res 13:1115-22. 2007
    ..One of those genes is plexin B1, a cell-surface receptor for the semaphorin Sema4D (CD 100). However, the biological role of plexin B1 in breast cancer is largely unknown...
  26. doi Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation
    Thomas Karn
    Department of Obstetrics and Gynecology, JW Goethe University, Frankfurt, Germany
    Eur J Cancer 48:12-23. 2012
    ..Oestrogen (ER) and human epidermal growth factor receptor 2 (HER2) receptors are strongly bimodally expressed genes in breast cancer...
  27. ncbi Gene expression of ceramide kinase, galactosyl ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancer
    Eugen Ruckhäberle
    Department of Obstetrics and Gynecology, J W Goethe University, Theodor Stern Kai 7, 60590 Frankfurt, Germany
    J Cancer Res Clin Oncol 135:1005-13. 2009
    ..Sphingolipids are bioactive lipids implicated in apoptosis, cell survival and proliferation. We analyzed the prognostic value of enzymes from sphingolipid metabolism in breast cancer...
  28. doi SATB1 gene expression and breast cancer prognosis
    Lars C Hanker
    Department of Obstetrics and Gynecology, J W Goethe University, Theodor Stern Kai 7, D 60590 Frankfurt, Germany
    Breast 20:309-13. 2011
    ....
  29. doi Predictive value of sphingosine kinase 1 expression in neoadjuvant treatment of breast cancer
    Eugen Ruckhäberle
    Department of Obstetrics and Gynecology, Goethe University Frankfurt, Theodor Stern Kai 7, 60590, Frankfurter, Germany
    J Cancer Res Clin Oncol 139:1681-9. 2013
    ..Sphingolipids play important roles in apoptosis and cell proliferation. Sphingosine kinase 1 (SphK1) expression has a prognostic impact in primary breast cancer, but its predictive value is currently unknown...
  30. ncbi Characterization of WNT7A expression in human endometrium and endometriotic lesions
    Regine Gaetje
    Department of Obstetrics and Gynecology, Johann Wolfgang Goethe University, Frankfurt, Germany
    Fertil Steril 88:1534-40. 2007
    ..To characterize the expression of WNT7A in human eutopic and ectopic endometrium...
  31. doi Acid ceramidase (AC)--a key enzyme of sphingolipid metabolism--correlates with better prognosis in epithelial ovarian cancer
    Lars Christian Hanker
    Department of Obstetrics and Gynecology, University of Homburg, Homburg, Germany
    Int J Gynecol Pathol 32:249-57. 2013
    ..These results are in contrast to the concept of AC as a promoter for cancer progression. Nevertheless, they are supported by the lately discovered tumor-suppressing function of sphingosine, the enzymatic product of AC...
  32. ncbi Extended breast cancer treatment with an aromatase inhibitor (Letrozole) after tamoxifen: why, who and how long?
    Manfred Kaufmann
    Department of Obstetrics and Gynaecology, Johann Wolfgang Goethe Universitat, Theodor Stern Kai 7, 60590 Frankfurt am Main, Germany
    Eur J Obstet Gynecol Reprod Biol 126:146-54. 2006
    ....
  33. ncbi Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis
    Pia Wülfing
    Department of Obstetrics and Gynecology, University of Munster, Albert Schweitzer Strasse 33, 48129, Munster, Germany
    J Cancer Res Clin Oncol 129:375-82. 2003
    ..The objective of this study was to evaluate breast carcinomas for the expression of cyclooxygenase-2 (Cox-2) using a tissue microarray (TMA) and to determine its clinical and prognostic relevance...
  34. ncbi Utero-tubal sperm transport and its impairment in endometriosis and adenomyosis
    Stefan Kissler
    Department Obstetrics and Gynecology, Johann Wolfgang Goethe University, Theodor Stern Kai 7, 60590 Frankfurt am Main, Germany
    Ann N Y Acad Sci 1101:38-48. 2007
    ..Hence, dysperistalsis is significantly associated with reduced spontaneous pregnancy rates. We therefore recommend MRI and HSSG in every sterility workup...
  35. ncbi Long-term risk of breast cancer recurrence: the need for extended adjuvant therapy
    Manfred Kaufmann
    Klinik fur Gynakologie und Geburtshilfe, J W Goethe Universität Frankfurt am Main, Theodor Stern Kai 7, 60590 Frankfurt am Main, Germany
    J Cancer Res Clin Oncol 131:487-94. 2005
    ..That trial, MA.17, evaluated letrozole as extended adjuvant treatment following standard adjuvant tamoxifen in postmenopausal women with predominantly estrogen receptor--and/or progesterone receptor--positive early breast cancer...
  36. ncbi Prognostic impact of fascin-1 (FSCN1) in epithelial ovarian cancer
    Lars C Hanker
    Department of Obstetrics and Gynecology, J W Goethe University, Theodor Stern Kai 7, 60590 Frankfurt, Germany
    Anticancer Res 33:371-7. 2013
    ..Fascin-1 (FSCN1) plays an important role in cancer development and is associated with invasion and metastasis. Therefore, we explored the expression and localization of FSCN1 in epithelial ovarian cancer (EOC)...
  37. ncbi Preoperative (neoadjuvant) systemic treatment of breast cancer
    Manfred Kaufmann
    Department of Obstetrics and Gynaecology, Johann Wolfgang Goethe University, Theodor Stern Kai 7, 60590 Frankfurt, Germany
    Breast 14:576-81. 2005
    ..PST will lead to individualised (tailored) treatment in patients with primary breast cancer...
  38. doi Prognostic impact of thymidine phosphorylase expression in breast cancer--comparison of microarray and immunohistochemical data
    E Ruckhäberle
    Department of Obstetrics and Gynecology, Goethe University, Frankfurt M, Germany
    Eur J Cancer 46:549-57. 2010
    ..In conclusion, the tumour infiltrating immune cells seem to be a major source of TP expression and predict a favourable prognosis in ER-negative breast cancer. Our data point to a role of TP in host immune response...
  39. ncbi Endometriosis may be generated by mimicking the ontogenetic development of the female genital tract
    Regine Gaetje
    Department of Obstetrics and Gynecology, Johann Wolfgang Goethe University, Frankfurt, Germany
    Fertil Steril 87:651-6. 2007
    ..To compare the expression of genes playing a decisive role during the embryonic development of the female genital tract (WNT4, WNT5A, WNT7A, PAX8) in the peritoneum of patients with endometriosis and control patients...
  40. ncbi Uterine contractility and directed sperm transport assessed by hysterosalpingoscintigraphy (HSSG) and intrauterine pressure (IUP) measurement
    Stefan Kissler
    Division of Gynecologic Endocrinology and Reproductive Medicine, Johann Wolfgang Goethe University, Frankfurt am Main, Germany
    Acta Obstet Gynecol Scand 83:369-74. 2004
    ..This study is the first to be designed to investigate utero-tubal transport function by HSSG and uterine contractility by intrauterine pressure measurement (IUP) consecutively on the same day in the periovulatory phase...
  41. ncbi Evaluation of the stereotactic 8G vacuum-assisted breast biopsy in the histologic evaluation of suspicious mammography findings (BI-RADS IV)
    Thomas Diebold
    Institute for Diagnostic and Interventional Radiology, J W G University Frankfurt Main, Germany
    Invest Radiol 40:465-71. 2005
    ..The purpose of this study was to evaluate the potential of the new 8G stereotactic vacuum-assisted breast biopsy (ST-driver, Mammotome; Ethicon Endosurgery) in the histologic evaluation of BI-RADS IV microcalcifications...
  42. ncbi [Integrin expression in eutopic and ectopic endometrium]
    R Gaetje
    Klinik fur Gynakologie und Geburtshilfe, Johann Wolfgang Goethe Universitat, Frankfurt
    Zentralbl Gynakol 128:135-7. 2006
    ..g., in the peritoneal fluid -- on the ectopic endometrium...
  43. ncbi [Cervical cancer screening of HIV-positive women: is a prolongation of the screening interval meaningful?]
    A Ahr
    Gynäkologische Praxis am Ziegelturm, Gelnhausen
    Zentralbl Gynakol 128:242-5. 2006
    ..Cervical cancer screening guidelines stated recently that the screening interval of healthy women can be extended up to 3 years. Can those recommendations be applied for high risk populations?..
  44. ncbi [Identification of preeclampsia by cDNA-gene expression profiling in human placentas and serum -- a pilot study]
    A Ahr
    Gynäkologische Praxis am Ziegelturm, Am Ziegelturm 4, 63571 Gelnhausen
    Zentralbl Gynakol 128:138-42. 2006
    ..With a new approach, the cDNA-Array analysis, human placentas and blood from preeclamptic and healthy pregnant women were examined for differentially expressed genes to find typical genes expression profiles...
  45. ncbi [Risk factors for recurrence of vulvar intraepithelial neoplasia III (VIN III)]
    A Ahr
    Gynäkologische Praxis am Ziegelturm, Gelnhausen
    Zentralbl Gynakol 128:347-51. 2006
    ..The therapy of VIN is the in toto resection. Still some patients develop VIN recurrence. The aim of this retrospective study is the identification of risk factors for VIN recurrence...
  46. doi Acid ceramidase 1 expression correlates with a better prognosis in ER-positive breast cancer
    E Ruckhäberle
    Departments of Obstetrics and Gynecology, J W Goethe University, Frankfurt, Germany
    Climacteric 12:502-13. 2009
    ..We investigated the relevance of ceramide- and sphingosine-generating enzymes in breast cancer (acid ceramidase 1 (ASAH1), ceramide synthases 4 (LASS4) and 6 (LASS6)) by means of gene expression analysis...
  47. doi The impact of the body mass index (BMI) on laparoscopic hysterectomy for benign disease
    David Bardens
    Department of Obstetrics and Gynecology, Saarland University Hospital, Kirrberger Str 100, 66421, Homburg, Germany
    Arch Gynecol Obstet 289:803-7. 2014
    ..To investigate the influence of the body mass index (BMI) on laparoscopic hysterectomy, including all intra- and postoperative findings and complications...
  48. ncbi Effect of humidified and heated CO2 during gynecologic laparoscopic surgery on analgesic requirements and postoperative pain
    Stefan Kissler
    Division of Gynecologic Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, Johann Wolfgang Goethe University, Theodor Stern Kai 7, D 60590 Frankfurt am Main, Germany
    J Am Assoc Gynecol Laparosc 11:473-7. 2004
    ..To determine the effect of humidified and heated CO(2) for pneumoperitoneum during laparoscopic surgery on analgesic requirements, postoperative pain, and patient satisfaction...
  49. ncbi [Sentinel lymph node biopsy in breast cancer]
    A Rody
    Klinik fur Gynakologie und Geburtshilfe, Klinikum der Johann Wolfgang Goethe Universitat, Frankfurt Main
    Chirurg 75:767-73. 2004
    ..Since many issues are controversial such as the prognostic value of micrometastases and extramammary nodes as well as the use of SNB after primary chemotherapy and in ductal carcinoma in situ, further clinical studies are necessary...
  50. doi Laparoscopic and laparotomic approaches for endometrial cancer treatment: a comprehensive review
    Ingolf Juhasz-Böss
    Department of Obstetrics and Gynecology, University of Saarland, Homburg, Saar, Germany
    Arch Gynecol Obstet 286:167-72. 2012
    ..Endoscopic surgery is gaining more popularity among surgeons as a safe and feasible option for treatment of endometrial carcinoma, providing the possibility of adequate lymph node excision...
  51. doi Prescribing preferences and personal experience of female gynaecologists in Germany and Austria regarding use of extended-cycle oral contraceptives
    Inka Wiegratz
    Centre of Obstetrics and Gynaecology, Department of Gynaecological Endocrinology and Reproductive Medicine, University Hospital of Frankfurt, Theodor Stern Kai 7, Frankfurt am Main, Germany
    Eur J Contracept Reprod Health Care 15:405-12. 2010
    ..To investigate prescribing preferences and personal experience of female gynaecologists with extended-cycle use of combined oral contraceptives (COCs) in Germany and Austria...
  52. ncbi Methylation of estrogen receptor beta promoter correlates with loss of ER-beta expression in mammary carcinoma and is an early indication marker in premalignant lesions
    A Rody
    Department of Gynecology, Johann Wolfgang Goethe University, Frankfurt, Germany
    Endocr Relat Cancer 12:903-16. 2005
    ..Interestingly, by comparing the promoter sequences of ER-beta with other genes known to be epigenetically inactivated in breast cancers, we identified a sequence motif possibly involved in promoter methylation...
  53. doi Clinical relevance of the putative stem cell marker p63 in breast cancer
    L Hanker
    Department of Obstetrics and Gynecology, J W Goethe University, Theodor Stern Kai 7, 60590 Frankfurt, Germany
    Breast Cancer Res Treat 122:765-75. 2010
    ..5). P63 is a positive prognostic factor in endocrine-treated ER positive breast cancer and might influence responsiveness to endocrine treatment. Thus, p63 could be helpful as a predictive factor for endocrine therapy...
  54. ncbi Uterotubal transport disorder in adenomyosis and endometriosis--a cause for infertility
    S Kissler
    Division of Gynaecologic Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynaecology, Johann Wolfgang Goethe University, Frankfurt am Main, Germany
    BJOG 113:902-8. 2006
    ....
  55. ncbi Clinical use of GnRH analogues
    L A Kiesel
    Department of Obstetrics and Gynaecology, University of Muenster, Germany
    Clin Endocrinol (Oxf) 56:677-87. 2002
  56. ncbi [Systemic therapy of operable carcinoma of the breast]
    M Kaufmann
    Universitats Frauenklinik, Frankfurt
    Zentralbl Gynakol 127:207-12. 2005
  57. ncbi Diminished pregnancy rates in endometriosis due to impaired uterotubal transport assessed by hysterosalpingoscintigraphy
    S Kissler
    Division of Gynaecologic Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynaecology, Johann Wolfgang Goethe University, Frankfurt Main, Germany
    BJOG 112:1391-6. 2005
    ..To investigate uterotubal transport by means of hysterosalpingoscintigraphy (HSSG) in women with and without endometriosis...
  58. ncbi Quantitative measurement of telomerase activity and localization of its catalytic subunit (hTERT) in chronic inflammation of capsule formation around various model implants and in sarcomas in a rat model
    O Bettendorf
    Institute of Pathology, University of Munster, Domagkstrasse 17, D 48149 Munster, Germany
    J Biomed Mater Res A 85:646-50. 2008
    ..So the quantitative measurement of telomerase activity should not be applied in general as a marker for malignancy in capsule tissue...
  59. ncbi Duration of dysmenorrhoea and extent of adenomyosis visualised by magnetic resonance imaging
    S Kissler
    Division of Gynaecologic Endocrinology and Reproductive Medicine, Johann Wolfgang Goethe University, Frankfurt Main, Germany
    Eur J Obstet Gynecol Reprod Biol 137:204-9. 2008
    ..This study was conducted to analyse the extent of adenomyosis using magnetic resonance imaging (MRI) and relate it to the duration of dysmenorrhoea...